Evidence map›Paper›PMID 24808363›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2014

Preemptive donor apoptotic cell infusions induce IFN-γ-producing myeloid-derived suppressor cells for cardiac allograft protection.

Jane Bryant, Nadine M Lerret, Jiao-Jing Wang, Hee-Kap Kang, James Tasch, Zheng Zhang, Xunrong Luo

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Donor macrophage depletion permits posttransplant tolerance induction in a murine islet transplant model.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Apoptotic Donor Cells in Transplantation.Frontiers in immunology · 2021
    Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Receptor tyrosine kinase MerTK suppresses an allogenic type I IFN response to promote transplant tolerance.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2019
    Article
  16. Review
  17. Apoptotic cell-based therapies for promoting transplantation tolerance.Current opinion in organ transplantation · 2018
    Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jane BryantDivision of Nephrology and Hypertension, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611;
Nadine M LerretDivision of Nephrology and Hypertension, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611;
Jiao-Jing WangComprehensive Transplant Center, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611; and.
Hee-Kap KangDivision of Nephrology and Hypertension, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611;
James TaschDivision of Nephrology and Hypertension, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611;
Zheng ZhangComprehensive Transplant Center, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611; and.
Xunrong LuoDivision of Nephrology and Hypertension, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611; Comprehensive Transplant Center, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611; and Department of Microbiology and Immunology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611 xunrongluo@northwestern.edu.

Funding

Alloantigen Delivery Via ECDI-Fixed Cells For Tolerance To Monkey Islet GraftsU01AI102463 · NIAID · UNIVERSITY OF MINNESOTA · PI HERING, BERNHARD JOSEF, LUO, XUNRONG · 2012 to 2016
$4.4M
Transplant Surgery Scientist Training ProgramT32DK077662 · NIDDK · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Richard M Green, Daniela P Ladner · 2007 to 2026
$3.8M
ECDI Coupled Cells for Tolerance in Allogeniec Islet Cell Transplantation for T1DDP2DK083099 · NIDDK · NORTHWESTERN UNIVERSITY AT CHICAGO · PI LUO, XUNRONG · 2008 to 2010
$2.4M
NIAID NIH HHS U01 AI102463NIDDK NIH HHS DP2 DK083099NIDDK NIH HHS T32 DK077662
6 · The paper itself

Abstract

We have previously shown that preemptive infusion of apoptotic donor splenocytes treated with the chemical cross-linker ethylcarbodiimide (ECDI-SPs) induces long-term allograft survival in full MHC-mismatched models of allogeneic islet and cardiac transplantation. The role of myeloid-derived suppressor cells (MDSCs) in the graft protection provided by ECDI-SPs is unclear. In this study, we demonstrate that infusions of ECDI-SPs increase two populations of CD11b(+) cells in the spleen that phenotypically resemble monocytic-like (CD11b(+)Ly6C(high)) and granulocytic-like (CD11b(+)Gr1(high)) MDSCs. Both populations suppress T cell proliferation in vitro and traffic to the cardiac allografts in vivo to mediate their protection via inhibition of local CD8 T cell accumulation and potentially also via induction and homing of regulatory T cells. Importantly, repeated treatments with ECDI-SPs induce the CD11b(+)Gr1(high) cells to produce a high level of IFN-γ and to exhibit an enhanced responsiveness to IFN-γ by expressing higher levels of downstream effector molecules ido and nos2. Consequently, neutralization of IFN-γ completely abolishes the suppressive capacity of this population. We conclude that donor ECDI-SPs induce the expansion of two populations of MDSCs important for allograft protection mediated in part by intrinsic IFN-γ-dependent mechanisms. This form of preemptive donor apoptotic cell infusions has significant potential for the therapeutic manipulation of MDSCs for transplant tolerance induction.

Indexed as

ApoptosisHeart TransplantationAllograftsAnimalsGraft SurvivalInterferon-gammaMaleMiceMice, Inbred BALB CMyeloid CellsSpleenInterferon-gamma

Identifiers

PMID24808363
PMCPMC4082999

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.